This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:


peer-reviewed publication

trusted source


New research signals a quantum leap for brain tumor treatment

brain tumor
Credit: Unsplash/CC0 Public Domain

Researchers have discovered a new way to target and kill cancer cells in hard-to-treat brain tumors using electrically charged molecules to trigger self-destruction, which could be developed into a spray treatment used during surgery.

A multidisciplinary team of researchers from the University of Nottingham, led by the School of Pharmacy found a new way to harness the extraordinary capabilities of bio-nanoantennae—gold nanoparticles intricately coated with specialized redox active molecules to induce programmed , or apoptosis, in on . The research has been published in Nature Nanotechnology.

The research focuses on patient-derived cells, an elusive and formidable form of brain that has long evaded effective treatment. The five-year survival rate for glioblastoma is only 6.8% and the average length if survival for patients is estimated to be only eight months from diagnosis.

The bio-nanoantennae were able to specifically target glioblastoma cells, leaving unscathed. This unprecedented level of precision opens up new possibilities for developing treatment for glioblastoma during surgical resection of the tumor, when the bio-nanoantennae would be sprayed or injected.

The researchers, which included experts from the Schools of Engineering, Physics and Medicine have now established what is thought to be the first "quantum therapeutic," which taps into the potential of quantum signaling to combat cancer.

Dr. Frankie Rawson led the research and explains, "The team showed that cancer cells succumb to the intricate dance of electrons, orchestrated by the enchanting world of quantum biology. With the advent of bio-nanoantennae, this vision of real-world quantum therapies edge closer to reality. By precisely modulating quantum biological electron tunneling, these ingenious nanoparticles create a symphony of electrical signals that trigger the cancer cells' natural self-destruction mechanism."

The team has now filed patent to begin translating the technology to this eventual clinical application. Further rigorous research and validation are essential to ensure the safety and effectiveness of bio-nanoantennae for human use.

Dr. Ruman Rahman from the School of Medicine and co-author of the study, adds, "Treating glioblastoma tumors has long presented challenges for clinicians and prognosis for patients is still poor, which is why any research showing the promise of a new effective treatment is hugely exciting. This research has shown the possibilities presented by quantum therapeutics as a new technology to communicate with biology. The fusion of quantum bioelectronics and medicine brings us one step closer to a new treatment paradigm for disease. "

More information: Wireless electrical–molecular quantum signalling for cancer cell apoptosis, Nature Nanotechnology (2023). DOI: 10.1038/s41565-023-01496-y ,

Journal information: Nature Nanotechnology

Citation: New research signals a quantum leap for brain tumor treatment (2023, September 14) retrieved 2 October 2023 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Consumer Health: What is glioblastoma?


Feedback to editors